Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pathology ; 31(2): 83-9, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10399160

RESUMO

An epidemiological study of childhood cancer in New Zealand identified 409 children aged 0 to 14 years with malignant neoplasms newly diagnosed between 1990 and 1993 inclusive. The original microscopic material on which the diagnoses were based was reviewed in 398 cases and the neoplasms were allocated into the 12 major groupings and 48 further subcategories of the International Classification of Childhood Cancer (ICCC). The pathology reviewers agreed with group and subcategory classification of the confirmed cancers in all but one case of acute leukemia and three cancers of the central nervous system. Changes were also made in the FAB classification of three cases of acute non-lymphocytic leukemia and in the further subcategorisation of three Hodgkin's lymphomas and ten astrocytomas. The results show a high level of diagnostic accuracy for confirmed childhood neoplasms in that time period. Nine of 15 cases of malignant melanoma notified to the study were not confirmed for various reasons, which included a change in the pathological diagnosis in four cases. Compared with Victoria (Australia), New Zealand has a high incidence rate of lymphomas in boys and an unusual female preponderance of Wilms' tumor cases.


Assuntos
Neoplasias/epidemiologia , Adolescente , Neoplasias Ósseas/epidemiologia , Neoplasias do Sistema Nervoso Central/epidemiologia , Criança , Pré-Escolar , Feminino , Humanos , Incidência , Lactente , Recém-Nascido , Neoplasias Renais/epidemiologia , Leucemia/epidemiologia , Neoplasias Hepáticas/epidemiologia , Linfoma/epidemiologia , Masculino , Neoplasias Embrionárias de Células Germinativas/epidemiologia , Neoplasias Epiteliais e Glandulares/epidemiologia , Neuroblastoma/epidemiologia , Nova Zelândia/epidemiologia , Retinoblastoma/epidemiologia , Sarcoma/epidemiologia , Sistema Nervoso Simpático
3.
Haemophilia ; 6(2): 66-70, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10781190

RESUMO

The experience with central venous implantable devices (portacaths) has been reviewed in children attending the Auckland Hospital Haemophilia Centre. Fourteen children had 23 portacaths inserted. Thirteen had severe Haemophilia A, of whom five had high responding inhibitors to factor VIII. All the children were HIV negative. Ages ranged from 4 months to 13 years at the time of initial placement and 12 were under 5 years. Indications for portacath placement included primary and secondary prophylaxis, induction of immune tolerance, prophylactic therapy post intracranial haemorrhage and poor venous access. Catheter-related infections occurred in 48% of cases. Staphylococcal species were the most common organisms isolated followed by gram-negative bacilli. 63% of the infections were successfully cleared with antibiotics. Haematoma formation occurred in 17% of catheters, primarily in patients who had high factor VIII inhibitor levels. Mechanical problems including blockage, leakage and extrusion of the portacath occurred less frequently (13%). The significant rate of infection in this immunocompetent population is consistent with other reports. Despite the obvious benefits of portacaths this complication is potentially serious and causes appreciable morbidity. In contrast, bleeding complication rates were relatively low.


Assuntos
Cateterismo Venoso Central , Hemofilia A/complicações , Hemofilia A/terapia , Adolescente , Infecções Bacterianas/tratamento farmacológico , Infecções Bacterianas/etiologia , Cateterismo Venoso Central/efeitos adversos , Cateteres de Demora/efeitos adversos , Criança , Pré-Escolar , Contaminação de Equipamentos , Falha de Equipamento , Fator VIII/imunologia , Hematoma/tratamento farmacológico , Hematoma/etiologia , Hemofilia A/imunologia , Hemofilia B/complicações , Hemofilia B/imunologia , Hemofilia B/terapia , Hemorragia/tratamento farmacológico , Hemorragia/etiologia , Humanos , Lactente , Isoanticorpos/efeitos adversos , Isoanticorpos/sangue , Masculino , Trombose/etiologia , Trombose/terapia , Fatores de Tempo , Infecção dos Ferimentos/tratamento farmacológico , Infecção dos Ferimentos/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA